Wegovy maker warns of 'painful' price cuts as shares plunge

Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Proudly powered by WordPress | Theme : News Elementor by BlazeThemes